Related Experiment Video
Updated: Jun 13, 2026

Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction
Published on: April 24, 2016
Salivary gland malignancy and radioiodine therapy for thyroid cancer
Joanna Klubo-Gwiezdzinska1, Douglas Van Nostrand, Kenneth D Burman
1Department of Medicine, Washington Hospital Center, Washington, DC 20010-2910, USA.
Background:
The risk of second primary malignancies in patients with well-differentiated thyroid cancer is of special interest because of the common use of radioactive iodine (RAI) ablation and/or treatment of these patients and the theoretical risk of subsequent nonthyroid malignancies associated with the radiation exposure. This brief report focuses specifically on the occurrence of second primary malignancies of the salivary glands. RAI residency within salivary tissues is known to have both acute and chronic consequences on salivary function, but secondary neoplasia is quite unusual.
Summary:
We present a very rare case of a patient with papillary thyroid cancer treated with 600 mCi of RAI, who subsequently developed salivary gland cancer.
Conclusions:
We recommend salivary gland protection to diminish potential side effects after the exposure to radioiodine. On the basis of our experience we suggest administration of sialogogues (such as lemon juice) continuously, every 30-60 minutes for 24 hours, after RAI administration.
Related Concept Videos
Goiter
Graves Disease II: Pathophysiology
Graves' Disease I: Introduction
Hyperthyroidism II: Pathophysiology
Salivary Glands and Saliva
The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

